12/13/2024
8:00 AM | Hughes Eric A (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2024
8:05 AM | Hughes Eric A (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
6:03 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
6:03 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:02 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:07 AM | Monte Rosa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
4:10 PM | Monte Rosa Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
|
10/28/2024
3:05 PM | Monte Rosa Therapeutics (Subject)
Wallace Owen B. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024
5:59 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
4:00 PM | Monte Rosa Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
09/24/2024
3:40 PM | Monte Rosa Therapeutics (Issuer)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:44 PM | Monte Rosa Therapeutics (Issuer)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:30 PM | Janku Filip (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:46 PM | Monte Rosa Therapeutics (Subject)
New Enterprise Associates 17, L.P. (Filed by)
| Form SC 13D/A | |
08/12/2024
4:07 PM | Monte Rosa Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
08/08/2024
6:02 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:04 AM | Monte Rosa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/09/2024
3:15 PM | Dunn Edmund (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:04 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
7:12 PM | Behbahani Ali (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
6:18 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:40 PM | Monte Rosa Therapeutics (Subject)
New Enterprise Associates 17, L.P. (Filed by)
| Form SC 13D/A | |
05/09/2024
6:45 AM | Monte Rosa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:05 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:24 PM | Jones Jullian G (Reporting)
Monte Rosa Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
11:58 AM | Monte Rosa Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A | |
03/14/2024
6:44 AM | Monte Rosa Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
6:05 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
10:22 AM | BlackRock Inc. (Filed by)
Monte Rosa Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
8:14 AM | Avoro Capital Advisors LLC (Filed by)
Monte Rosa Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Monte Rosa Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
6:47 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:15 PM | Monte Rosa Therapeutics (Issuer)
Nickson Philip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Dunn Edmund (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Janku Filip (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Jones Jullian G (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Monte Rosa Therapeutics (Issuer)
Wallace Owen B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Monte Rosa Therapeutics (Issuer)
Warmuth Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
